Optimizing levodopa therapy, when and how? Perspectives on the importance of delivery and the potential for an early combination approach.
Andrew Lees, Eduardo Tolosa, Fabrizio Stocchi...
https://pubmed.ncbi.nlm.nih.gov/36729395/Actively Recruiting
Led by safia bano · Updated on 2026-09-14
88
Participants Needed
1
Research Sites
N/A
Total Duration
Researchers are comparing two drugs, benzhexol and procyclidine, to see how well they improve tremor in adults with tremor-predominant Parkinsons disease who are already taking levodopa. The study aims to find out if benzhexol provides similar tremor improvement as procyclidine while monitoring side effects. Participants must have Parkinsons disease with predominant tremor, be aged 40 to 70, and have certain stages of disease severity. Participants will be randomly assigned to receive either benzhexol or procyclidine alongside their usual levodopacarbidopa treatment. Benzhexol dosing starts at 2 mg daily and increases over the first week to 2 mg three times daily, with doses adjusted based on tremor control and side effects. Procyclidine starts at 2.5 mg three times daily and increases during the first week up to 5 mg three times daily, also adjusted for response and tolerability. Treatment lasts up to 6 months. Participants will have motor symptoms and side effects assessed at baseline, 2 weeks, 3 months, and 6 months. Motor function is measured using the Movement Disorder Society Unified Parkinsons Disease Rating Scale, focusing on tremor severity in various body parts. Side effects and medication tolerability are closely monitored throughout the study. The main outcome is the change in tremor score at 2 weeks after treatment begins.
CONDITIONS
Comparison of Benzhexol and Procyclidine for Tremor in Tremor-Predominant Parkinson's Disease
S
Saad A Malik, MBBS
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
safia bano
Lead Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Duration - 6 months
Participants receive either benzhexol or procyclidine in addition to their usual levodopa/carbidopa therapy. Dosages will be gradually increased during the first week and adjusted based on tremor response and side effects. Treatment continues for up to 6 months.
Assessments at baseline, 2 weeks, 3 months, and 6 months
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Andrew Lees, Eduardo Tolosa, Fabrizio Stocchi...
https://pubmed.ncbi.nlm.nih.gov/36729395/Zejin Ou, Jing Pan, Shihao Tang...
https://pubmed.ncbi.nlm.nih.gov/34950630/Shaoyi Peng, Peng Liu, Xiaowen Wang...
https://pubmed.ncbi.nlm.nih.gov/40269818/Gabriel E Vázquez-Vélez, Huda Y Zoghbi
https://pubmed.ncbi.nlm.nih.gov/34236893/Lulup Kumar Sahoo, Vikram Venkappayya Holla, Dhruv Batra...
https://pubmed.ncbi.nlm.nih.gov/33037478/Matthew J Barrett, Lana Sargent, Huma Nawaz...
https://pubmed.ncbi.nlm.nih.gov/34765683/Christopher G Goetz, Barbara C Tilley, Stephanie R Shaftman...
https://pubmed.ncbi.nlm.nih.gov/19025984/safia bano
Lead Sponsor